PE20190225A1 - Un metodo para reducir la contaminacion de huevo - Google Patents

Un metodo para reducir la contaminacion de huevo

Info

Publication number
PE20190225A1
PE20190225A1 PE2018003114A PE2018003114A PE20190225A1 PE 20190225 A1 PE20190225 A1 PE 20190225A1 PE 2018003114 A PE2018003114 A PE 2018003114A PE 2018003114 A PE2018003114 A PE 2018003114A PE 20190225 A1 PE20190225 A1 PE 20190225A1
Authority
PE
Peru
Prior art keywords
reduce egg
egg contamination
contamination
reduce
salmonella
Prior art date
Application number
PE2018003114A
Other languages
English (en)
Inventor
Immerseel Filip Van
Ruth Raspoet
Richard Ducatelle
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of PE20190225A1 publication Critical patent/PE20190225A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion se refiere a cepas mutantes de Salmonella y a su uso como una vacuna para prevenir la infeccion por Salmonella, en particular en huevos
PE2018003114A 2016-05-26 2017-05-23 Un metodo para reducir la contaminacion de huevo PE20190225A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16171540 2016-05-26
PCT/EP2017/062330 WO2017202804A1 (en) 2016-05-26 2017-05-23 A method of reducing egg contamination

Publications (1)

Publication Number Publication Date
PE20190225A1 true PE20190225A1 (es) 2019-02-13

Family

ID=56116217

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2018003114A PE20190225A1 (es) 2016-05-26 2017-05-23 Un metodo para reducir la contaminacion de huevo

Country Status (9)

Country Link
US (2) US10842861B2 (es)
EP (1) EP3463442A1 (es)
CN (1) CN109496156A (es)
BR (1) BR112018074107A2 (es)
CA (1) CA3025410A1 (es)
MX (1) MX2018014532A (es)
PE (1) PE20190225A1 (es)
RU (1) RU2018145441A (es)
WO (1) WO2017202804A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017202804A1 (en) * 2016-05-26 2017-11-30 Universiteit Gent A method of reducing egg contamination
CN114532295B (zh) * 2022-03-19 2024-04-16 广西参皇养殖集团有限公司 一种优质鸡育种核心群白血病与鸡白痢联合净化的方法
CN114854654B (zh) * 2022-04-06 2023-12-15 青岛易邦生物工程有限公司 一种肠炎沙门氏菌活疫苗

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0511203D0 (en) * 2005-06-02 2005-07-06 Univ Birmingham Vaccines
WO2017202804A1 (en) * 2016-05-26 2017-11-30 Universiteit Gent A method of reducing egg contamination

Also Published As

Publication number Publication date
EP3463442A1 (en) 2019-04-10
CN109496156A (zh) 2019-03-19
RU2018145441A3 (es) 2020-08-21
US20210145954A1 (en) 2021-05-20
US10842861B2 (en) 2020-11-24
MX2018014532A (es) 2019-05-20
CA3025410A1 (en) 2017-11-30
BR112018074107A2 (pt) 2019-03-06
RU2018145441A (ru) 2020-06-26
WO2017202804A1 (en) 2017-11-30
US20190192647A1 (en) 2019-06-27

Similar Documents

Publication Publication Date Title
MX2021004479A (es) Agentes biologicos y su uso en plantas.
EA201990566A1 (ru) Композиции, содержащие бактериальные штаммы
UY37563A (es) Aislados de bacillus y usos de los mismos
CO2017002170A2 (es) Terapia de combinación para tratar un paramixovirus
MX390064B (es) Formas cristalinas de mononucleotido de beta-nicotinamida.
BR112016018654A2 (pt) Composições de silicato estabilizadas e seu uso como composições antiperspirantes
MX373660B (es) Fibroblastos de embrion de pollo inmortalizados.
AR091582A1 (es) Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas
MX2021010060A (es) Produccion de virus en huevos aviares.
ECSP18001613A (es) Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas
MX2017000775A (es) Vacunas de meningococos.
AR105287A1 (es) Desarrollo de una levadura reductora de la asparagina mediante evolución adaptiva y usos de la misma para reducir la formación de acrilamida
BR112017003462A2 (pt) coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino.
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
BR112017013498B8 (pt) Formulação agrícola, seu método de preparação, e composição agrícola aquosa
BR112016024096A2 (pt) novo bacteriófago e composição compreendendo o mesmo
MX387170B (es) Administración in ovo de cultivos probióticos.
MX382864B (es) Formulaciones de anticuerpos cristalinos.
CL2016003107A1 (es) Vacunas guiadas por anticuerpos y métodos de uso para generar respuestas inmunitarias maduras rápidas
MX2016013277A (es) Vacuna para estreptococo de grupo a.
MX2016014166A (es) Compuestos de triaminopirimidina utiles para evitar o tratar la malaria.
CR20160369A (es) Composiciones para uso en el tratamiento de afecciones alérgicas
BR112018074107A2 (pt) método para a redução da contaminação de ovos
CL2016001906A1 (es) Vacunas contra el reovirus aviar.
DOP2018000247A (es) Procedimiento para la preparación de cuerpos moldeados para la administración a animales